Myomo Affirms FY2026 Sales Guidance of $43.000M-$46.000M vs $48.591M Est

Benzinga Newsdesk www.benzinga.com Positive 45.5%

Neg 0% Neu 0% Pos 45.5%

Myomo (AMEX:MYO) affirms FY2026 sales outlook from $43.000 million-$46.000 million to $43.000 million-$46.000 million vs $48.591 million estimate.